Loading...

ELITE PHARMACEUTICALS INC Product Launches 8-K Filing

LT P

ELITE PHARMACEUTICALS INC

()

2025 8-K

Product Launch Announcement

Financial Results Report

Conference Call Announcement

Quarterly Financial Report

Conference Call Update

FDA Approval Granted

Conference Call Announcement

Quarterly Results Update

Financial Statements

Clinical Trials

New Product Launches

Product Shipment

Quarterly Results

External Links:

On April 30, 2025, Elite Pharmaceuticals Inc. announced the launch of its generic version of Percocet® (oxycodone and acetaminophen) in three dosages under the Elite Laboratories label.

AI Assistant

ELITE PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.